{"id":"any-treatment-for-cluster-headache","safety":{"commonSideEffects":[{"rate":"10-20%","effect":"Injection site reactions"},{"rate":"10-20%","effect":"Headache"},{"rate":"5-10%","effect":"Nausea"},{"rate":"5-10%","effect":"Dizziness"}]},"_chembl":{"chemblId":"CHEMBL219390","moleculeType":"Small molecule"},"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"By binding to the CGRP receptor, the drug reduces the release of pro-inflammatory neuropeptides, thereby inhibiting the transmission of pain signals in the brain. This leads to a decrease in the frequency and severity of cluster headache attacks.","oneSentence":"This drug targets the calcitonin gene-related peptide (CGRP) receptor to prevent cluster headache attacks.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T02:28:35.836Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Cluster headache prevention"}]},"trialDetails":[{"nctId":"NCT06950281","phase":"PHASE2","title":"Efficacy, Safety and Tolerability of Low Sodium Oxybate for Nocturnal Cluster Headache Attacks","status":"NOT_YET_RECRUITING","sponsor":"Leiden University Medical Center","startDate":"2026-01","conditions":"Chronic Cluster Headache","enrollment":52},{"nctId":"NCT04839900","phase":"NA","title":"Proactive Community Case Management for Malaria in Zambia","status":"COMPLETED","sponsor":"PATH","startDate":"2021-04-15","conditions":"Malaria, Falciparum, Malaria","enrollment":10890},{"nctId":"NCT02895256","phase":"","title":"Long-term Prognosis of Cluster Headache: a Retrospective Cohort Study","status":"UNKNOWN","sponsor":"Samsung Medical Center","startDate":"2016-04","conditions":"Cluster Headache, Disease Course","enrollment":70},{"nctId":"NCT02168764","phase":"NA","title":"Sphenopalatine Ganglion Stimulation for the Treatment of Chronic Cluster Headache","status":"UNKNOWN","sponsor":"Autonomic Technologies, Inc.","startDate":"2014-07","conditions":"Chronic Cluster Headache","enrollment":120}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_2","status":"active","brandName":"Any treatment for cluster headache","genericName":"Any treatment for cluster headache","companyName":"Samsung Medical Center","companyId":"samsung-medical-center","modality":"Small molecule","firstApprovalDate":"","aiSummary":"This drug targets the calcitonin gene-related peptide (CGRP) receptor to prevent cluster headache attacks. Used for Cluster headache prevention.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}